Cognitive decline in Parkinson disease

Dag Aarsland,Byron Creese,Marios Politis,K. Ray Chaudhuri,Dominic H. ffytche,Daniel Weintraub,Clive Ballard
DOI: https://doi.org/10.1038/nrneurol.2017.27
IF: 38.1
2017-03-03
Nature Reviews Neurology
Abstract:Key PointsThe full spectrum of cognitive impairment, from subjective cognitive decline to dementia, has been observed in Parkinson disease (PD)Mild cognitive impairment in PD usually progresses to dementia, but can be stable and even revert in some patientsThe aetiology of cognitive impairment in PD has not been fully elucidated, but limbic and cortical Lewy body pathology seems to be the main causeAmyloid plaque pathology also contributes to cognitive decline in PD, and amyloid pathology detected by cerebrospinal fluid analysis and imaging can predict subsequent dementiaOther probable mechanisms include genetics, synaptic pathology, neurotransmitter changes and inflammationCholinesterase inhibitors have symptomatic effects, but no disease-modifying treatments are available to reduce the risk of dementia in PD
clinical neurology
What problem does this paper attempt to address?